XNAS:BGMD BG Medicine Inc Insider Activity 4 Filing - 4/17/2012

Effective Date 4/17/2012

XNAS:BGMD (BG Medicine Inc): Fair Value Estimate
Premium
XNAS:BGMD (BG Medicine Inc): Consider Buying
Premium
XNAS:BGMD (BG Medicine Inc): Consider Selling
Premium
XNAS:BGMD (BG Medicine Inc): Fair Value Uncertainty
Premium
XNAS:BGMD (BG Medicine Inc): Economic Moat
Premium
XNAS:BGMD (BG Medicine Inc): Stewardship
Premium
 
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
van der Meer Pieter
  2. Issuer Name and Ticker or Trading Symbol
BG Medicine, Inc. [BGMD]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O GILDE HEALTHCARE PARTNERS, NEWTONLAAN 91 3584 BP
3. Date of Earliest Transaction (Month/Day/Year)
04/17/2012
(Street)

UTRECHT, P7 
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/17/2012   S   200,000 D $6.6 1,635,432 I By Gilde Europe Food & Agribusiness Fund B.V.(1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
van der Meer Pieter
C/O GILDE HEALTHCARE PARTNERS
NEWTONLAAN 91 3584 BP
UTRECHT, P7 
    X    
Gilde Europe Food & Agribusiness Fund B.V.
C/O GILDE HEALTHCARE PARTNERS
NEWTONLAAN 91 3584 BP
UTRECHT, P7 
    X    
Gilde Agribusiness Management B.V.
C/O GILDE HEALTHCARE PARTNERS
NEWTONLAAN 91 3584 BP
UTRECHT, P7 
    X    
Gilde Healthcare Holding B.V.
C/O GILDE HEALTHCARE PARTNERS
NEWTONLAAN 91 3584 BP
UTRECHT, P7 
    X    
de Graaf Edwin
C/O GILDE HEALTHCARE PARTNERS
NEWTONLAAN 91 3584 BP
UTRECHT, P7 
    X    
Perret Marc Olivier
C/O GILDE HEALTHCARE PARTNERS
NEWTONLAAN 91 3584 BP
UTRECHT, P7 
    X    
Gilde Europe Food & Agribusiness Partners II C.V.
C/O GILDE HEALTHCARE PARTNERS
NEWTONLAAN 91 3584 BP
UTRECHT, P7 
    X    

Signatures

 /s/ Pieter van der Meer   04/19/2012
** Signature of Reporting Person Date

 /s/ Edwin de Graaf   04/19/2012
** Signature of Reporting Person Date

 /s/ Marc Olivier Perret   04/19/2012
** Signature of Reporting Person Date

 /s/ Pieter van der Meer, Partner, Gilde Europe Food & Agribusiness Fund B.V.   04/19/2012
** Signature of Reporting Person Date

 /s/ Pieter van der Meer, Partner, Gilde Agribusiness Management B.V.   04/19/2012
** Signature of Reporting Person Date

 /s/ Pieter van der Meer, Partner, Gilde Healthcare Holding B.V.   04/19/2012
** Signature of Reporting Person Date

 /s/ Pieter van der Meer, Partner, Gilde Europe Food & Agribusiness Partners II C.V.   04/19/2012
** Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The manager of Gilde Europe Food & Agribusiness Fund B.V. is Gilde Agribusiness Management B.V., which is indirectly owned by three managing partners, Pieter van der Meer, Edwin de Graaf and Marc Olivier Perret, through a holding entity, Gilde Healthcare Holding B.V. Gilde Healthcare Holding B.V. is owned in equal thirds by the three managing partners. Gilde Europe Food & Agribusiness Partners II C.V. and Gilde Agribusiness Management B.V. respectively have a 15% and 5% carried interest in Gilde Europe Food & Agribusiness Fund B.V. Pieter van der Meer, Edwin de Graaf and Marc Olivier Perret together have a controlling interest in Gilde Europe Food & Agribusiness Partners II C.V. Each of Pieter van der Meer, Edwin de Graaf, and Marc Olivier Perret disclaim beneficial ownership of the securities except to the extent of his pecuniary interest therein.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

XNAS:BGMD BG Medicine Inc Insider Activity 4 Filling

BG Medicine Inc XNAS:BGMD Stock - Get Insider Activity SEC Filing of BG Medicine Inc XNAS:BGMD stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

Content Partners
XNAS:BGMD BG Medicine Inc Insider Activity 4 Filing - 4/17/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: XNAS:BGMD BG Medicine Inc Insider Activity 4 Filing - 3/19/2012  |  Next: XNAS:BGMD BG Medicine Inc Insider Activity 4 Filing - 5/17/2012